Drug intelligence / Profile preview

Lycomato

Development stage
Unknown
Lead developer
Lycored
Modality
Small Molecules
Administration
Oral
01

Overview

Lycomato (recently rebranded as Lycomato6™) is a proprietary, standardized tomato extract developed by Lycored from a specific breed of non-GMO tomatoes. It is an oral dietary supplement formulated as an oleoresin containing a synergistic complex of six standardized phytonutrients: lycopene, phytoene, phytofluene, beta-carotene, tocopherols (Vitamin E), and phytosterols. The formulation is designed to combat oxidative stress and inflammation by neutralizing free radicals and inhibiting collagen-degrading enzymes such as matrix metalloproteinase-1 (MMP-1). Additionally, it supports mitochondrial health by promoting mitophagy and reducing cellular damage. Lycomato is primarily marketed as a 'beauty-from-within' ingredient for skin health, with clinical evidence supporting its ability to improve skin elasticity, reduce wrinkles, and protect against photoaging and oxidative stress-induced damage.

Brand names
LycomatoLycomato6Lycomato-6Lycomato 6
Other names
Standardized tomato extractLycored tomato oleoresin
02

Targets

MMP1 (Matrix metalloproteinase-1)

Beyond the preview

Go deeper on Lycomato.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lycomato.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call